Astrid Kimmig

422 total citations
11 papers, 362 citations indexed

About

Astrid Kimmig is a scholar working on Immunology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Astrid Kimmig has authored 11 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 4 papers in Infectious Diseases and 3 papers in Molecular Biology. Recurrent topics in Astrid Kimmig's work include Antifungal resistance and susceptibility (3 papers), Neuroblastoma Research and Treatments (3 papers) and Fungal Infections and Studies (3 papers). Astrid Kimmig is often cited by papers focused on Antifungal resistance and susceptibility (3 papers), Neuroblastoma Research and Treatments (3 papers) and Fungal Infections and Studies (3 papers). Astrid Kimmig collaborates with scholars based in Germany, United States and Ireland. Astrid Kimmig's co-authors include Rupert Handgretinger, D. Niethammer, Gregory R. Kardos, Manfred Neumann, H. Diddens, Volker Gekeler, Peter Lang, Ingo Müller, Michaela Döring and Annika Erbacher and has published in prestigious journals such as Blood, BMC Infectious Diseases and European Journal of Clinical Microbiology & Infectious Diseases.

In The Last Decade

Astrid Kimmig

10 papers receiving 355 citations

Peers

Astrid Kimmig
Ralf Häfer Germany
Astrid Kimmig
Citations per year, relative to Astrid Kimmig Astrid Kimmig (= 1×) peers Ralf Häfer

Countries citing papers authored by Astrid Kimmig

Since Specialization
Citations

This map shows the geographic impact of Astrid Kimmig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Astrid Kimmig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Astrid Kimmig more than expected).

Fields of papers citing papers by Astrid Kimmig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Astrid Kimmig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Astrid Kimmig. The network helps show where Astrid Kimmig may publish in the future.

Co-authorship network of co-authors of Astrid Kimmig

This figure shows the co-authorship network connecting the top 25 collaborators of Astrid Kimmig. A scholar is included among the top collaborators of Astrid Kimmig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Astrid Kimmig. Astrid Kimmig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Döring, Michaela, Sabine Haufe, Ulrike Hartmann, et al.. (2013). Comparison of itraconazole, voriconazole, and posaconazole as oral antifungal prophylaxis in pediatric patients following allogeneic hematopoietic stem cell transplantation. European Journal of Clinical Microbiology & Infectious Diseases. 33(4). 629–638. 42 indexed citations
2.
Döring, Michaela, Carsten Müller, Annika Erbacher, et al.. (2012). Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12 years of age following allogeneic stem cell transplantation. BMC Infectious Diseases. 12(1). 263–263. 48 indexed citations
4.
Handgretinger, Rupert, Gernot Bruchelt, Astrid Kimmig, et al.. (1990). In Vitro and In Vivo Effect of Interleukin-2 on the 2′,5′-Oligoadenylate Synthetase Activity of Peripheral Mononuclear Blood Cells. Journal of Interferon Research. 10(1). 75–82. 4 indexed citations
5.
Kimmig, Astrid, Volker Gekeler, Manfred Neumann, et al.. (1990). Susceptibility of multidrug-resistant human leukemia cell lines to human interleukin 2-activated killer cells.. PubMed. 50(21). 6793–9. 187 indexed citations
6.
Handgretinger, R., R. Dopfer, Sabine E. Hammer, et al.. (1990). The efficiency of a new cell separation technique in bone marrow purging without damaging the purged tumor cells.. PubMed. 333. 303–9. 3 indexed citations
7.
Handgretinger, Rupert, Astrid Kimmig, D. Schmidt, et al.. (1990). Establishment and characterization of a cell line (Wa-2) derived from an extrarenal rhabdoid tumor.. PubMed. 50(7). 2177–82. 32 indexed citations
8.
Handgretinger, R., Astrid Kimmig, Philippe Lang, et al.. (1989). Interferon-gamma upregulates the susceptibility of human neuroblastoma cells to interleukin-2-activated natural killer cells.. PubMed. 8(4). 189–96. 18 indexed citations
9.
Handgretinger, Rupert, et al.. (1989). In Vitro Induction of Lymphokine-Activated Killer (Lak) Activity in Patients with Neuroblastoma. Pediatric Hematology and Oncology. 6(4). 307–317. 9 indexed citations
10.
Bruchelt, Gernot, Rupert Handgretinger, Gerhard Fierlbeck, et al.. (1989). Lysis of neuroblastoma cells by the ADCC-reaction: granulocytes of patients with chronic granulomatous disease are more effective than those of healthy donors. Immunology Letters. 22(3). 217–220. 9 indexed citations
11.
Bruchelt, Gernot, Rupert Handgretinger, Astrid Kimmig, et al.. (1989). Effects of granulocytes on human neuroblastoma cells measured by chemiluminescence and chromium‐51 release assay. Journal of Bioluminescence and Chemiluminescence. 3(2). 93–96. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026